All Resources
Exploring Early Detection of Autoimmune Type 1 Diabetes
Screening for autoimmune T1D involves testing for autoantibodies that are markers of destruction of insulin-producing beta cells.
Autoimmunity in Type 1 Diabetes: A Pathophysiology Snapshot
T1D is an autoimmune disease whereby autoreactive T-cells drive progressive beta-cell damage and destruction, ultimately leading to insulin deficiency, dysglycemia, and hyperglycemia.
From Presymptomatic to Insulin Dependence: The Stages of Autoimmune Type 1 Diabetes
An overview of the stages of autoimmune type 1 diabetes, from the development of autoimmunity through to insulin dependence.
Exploring the Pathophysiology of Autoimmune Type 1 Diabetes
Type 1 diabetes is underpinned by autoimmune activity against insulin-producing beta cells, as explained in this video.
Metabolic Monitoring in Individuals with Presymptomatic Autoimmune Type 1 Diabetes
A brief overview of the tools available for monitoring people with presymptomatic autoimmune type 1 diabetes, and the pros and cons for each method.
Early Identification of Type 1 Diabetes: Who Might Benefit from Screening for Autoantibodies?
Why and Who: an overview of the key considerations and decisions that inform screening people for islet autoantibodies.
Monitoring of Presymptomatic Type 1 Diabetes
Monitoring people with early-stage autoimmune T1D may reduce the risk of serious complications, such as DKA.
Exploring the Impact of Diagnosis
The burden associated with a diagnosis of autoimmune T1D can be wide-ranging. This video describes the impact of diagnosis on an individual and their family.